18. R. van Leeuwen, S. Boekhoorn, et al., “Dietary Intake of Antioxidants and Risk of Age-Related Macular Degeneration,” JAMA 2005; 294 (24): 3101–3107.
19. http://www.medscape.com/viewarticle/520823
20. I. S. Kwun, K. H. Park, et al., “Lower Antioxidant Vitamins (A, C and E) and Trace Minerals (Zn, Cu, Mn, Fe and Se) Status in Patients with Cerebrovascular Disease,” Nutr Neurosci, 2005; 8 (4): 251–257.
21. J. A. Pasco, M. J. Henry, et al., “Antioxidant Vitamin Supplements and Markers of Bone Turnover in a Community Sample of Nonsmoking Women,” J Womens Health (Larchmont), 2006; 15 (3): 295–300.
22. S. Das, R. Ray, et al., “Effect of Ascorbic Acid on Prevention of Hypercholesterolemia Induced Atherosclerosis,” Mol Cell Biochem 2006 February 14.
23. http://www.medicalnewstoday.com/medicalnews.php?newsid=40914
24. M. Akmal, J. Q. Qadri, et al., “Improvement in Human Semen Quality After Oral Supplementation of Vitamin C,” J Med Food 2006; 9 (3): 440–442.
25. S. Sasazuki, S. Sasaki, et al., “Effects of Vitamin C on Common Cold: Randomized Controlled Trial,” European Journal of Clinical Nutrition, August 24, 2005 (e-published ahead of print).
26. http://www.medscape.com/viewarticle/493649
27. B. T. Drewel, D. W. Giraud, et al., “Less Than Adequate Vitamin E Status Observed in a Group of Preschool Boys and Girls Living in the United States,” The J of Nutr Biochem 2006; 17 (2): 132–138.
28. http://www.abcnews.go.com/Health/wireStory?id=544848
29. M. P. Malafa, F. D. Fokum, et al., “Vitamin E Succinate Suppresses Prostate Tumor Growth by Inducing Apoptosis,” Int J Cancer 2005 (E-published ahead of print).
30. P. W. Sylvester and S. J. Shah, “Mechanisms Mediating the Antiproliferative and Apoptotic Effects of Vitamin E in Mammary Cancer Cells,” Front Biosci 2005 January 1; 10: 699–709.
31. A. Cherubini, A. Martin, et al., “Vitamin E Levels, Cognitive Impairment and Dementia in Older Persons: The InCHIANTI Study,” Neurobiol Aging 2005; 26 (7): 987–994.
32. Z. El-Akawi, N. Abdel-Latif, et al., “Does the Plasma Level of Vitamins A and E Affect Acne Condition?” Clin Exp Dermatol 2006; 31 (3): 430–433.
33. A. L. Ray, R. D. Semba, et al., “Low Serum Selenium and Total Carotenoids Predict Mortality Among Older Women Living in the Community: The Women’s Health and Aging Studies,” J Nutr 2006; 136 (1): 172–176.
34. J. Marniemi, “Dietary and Serum Vitamins and Minerals as Predictors of Myocardial Infarction and Stroke in Elderly Subjects,” Nutr Metab Cardiovasc Dis 2005 June; 15 (3): 188–197. 43761 (10/2005)
35. S. A. Hanninen, P. B. Darling, et al., “The Prevalence of Thiamin Deficiency in Hospitalized Patients with Congestive Heart Failure,” Journal of the American College of Cardiology 2006; 47: 354–361.
36. Neuropsychology 1995; 32: 98–105.
37. “Thiamine Supplementation, Mood and Cognitive Functioning,” Psychopharmacology 1997; 129: 66–71. #26997
38. “Red Cell Transketolase Studies in a Private Practice Specializing in Nutritional Correction,” Journal of the American College of Nutrition 1988; 7 (1): 61–67, and Interview in Medical Pearls with Kirk Hamilton #29204.
39. M. Gold, “Plasma and Red Blood Cell Thiamin Deficiency in Patients with Dementia of the Alzheimer’s Type,” Archives of Neurology, November 1995; 52: 1081–1085. #23739
40. Y. Miyake, S. Sasaki, et al., “Dietary Folate and Vitamins B12, B6, and B2 Intake and the Risk of Postpartum Depression in Japan: The Osaka Maternal and Child Health Study,” J Affect Disord 2006 June 29 (E-published ahead of print).
41. http://www.my.webmd.com/content/Article/90/100791.htm
42. Y. Osono, N. Hirose, K. Nakajima, and Y. Hata, “The Effects of Pantethine on Fatty Liver and Fat Distribution,” J Atheroscler Thromb 2000; 7 (1): 55–58.
43. C. H. Cheng, S. J. Chang, et al., “Vitamin B6 Supplementation Increases Immune Responses in Critically Ill Patients,” Eur J Clin Nutr 2006; 60 (10): 1207–1213.
44. P. T. Lin, C. H. Cheng, et al., “Low Pyridoxal 5´Phosphate Is Associated with Increased Risk of Coronary Artery Disease,” Nutrition 2006 October 9 (E-published ahead of print).
45. http://www.medscape.com/viewarticle/506337; Gastroenterology June 2005; 128: 1830–1837.
46. J. Lindenbaum, E. B. Healton, D. G. Savage, et al., “Neuropsychiatric Disorders Caused by Cobalamin Deficiency in the Absence of Anemia or Macrocytoses,” New England Journal of Medicine 318 (26) (30 June 1988): 1720–1728.
47. J. Lindenbaum, I. H. Rosenberg, P. W. Wilson, et al., “Prevalence of Cobalamin Deficiency in the Framingham Elderly Population,” American Journal of Clinical Nutrition 60 (1) (July 1994): 2–11.
48. W. S. Beck, “Cobalamin and the Nervous System,” editorial, New England Journal of Medicine 318 (1988): 1752–1754.
49. D. S. Karnaze and R. Carmel, “Low Serum Cobalamin Levels in Primary Degenerative Dementia: Do Some Patients Harbor Atypical Cobalamin Deficiency States?” Archives of Internal Medicine 147 (3) (March 1987): 429–431.
50. B. Regland, M. Andersson, L. Abrahamsson, et al., “Increased Concentrations of Homocysteine in the Cerebrospinal Fluid in Patients with Fibromyalgia and Chronic Fatigue Syndrome,” Scandinavian Journal of Rheumatology 26 (4) (1997): 301–307.
51. V. Lerner, “Vitamin B12 and Folate Serum Levels in Newly Admitted Psychiatric Patients,” Clin Nutr, 2006 February; 25 (1): 60–67. E-published 2005 October 10. 44868 (6/2006).
52. R. A. Dhonukshe-Rutten et al. “Homocysteine and Vitamin B12 Status Relate to Bone Turnover Markers, Broadband Ultrasound Attenuation, and Fractures in Healthy Elderly People,” J Bone Miner Res 2005 June; 20 (6): 921–929; and M. S. Morris, P. F. Jacques, and J. Selhub, “Relation Between Homocysteine and B-vitamin Status Indicators and Bone Mineral Density in Older Americans,” Bone 2005; 37 (2).
53. J. Robertson, F. Iemolo, et al., “Vitamin B12, Homocysteine and Carotid Plaque in the Era of Folic Acid Fortification of Enriched Cereal Grain Products,” CMAJ 2005; 172 (12): 1569–1573.
54. D. E. Diaz, A. M. Tuesta, M. D. Ribo, et al., “Low Levels of Vitamin B12 and Venous Thromboembolic Disease in Elderly Men,” Journal of Internal Medicine 2005; 258 (3): 244–249.
55. M. Lajous et al., “Folate, Vitamin B6, and Vitamin B12 Intake and the Risk of Breast Cancer Among Mexican Women,” Cancer Epidemiology Biomarkers & Prevention, Vol. 15, March 2006, 443–448.
56. http://www.latimes.com/news/nationworld/nation/wire/ats-ap_health10jun 20,1,7209352.story?coll=sns-ap-tophealth&ctrack=1&cset=true
57. G. Ravaglia, P. Forti, et al., “Homocysteine and Folate as Risk Factors for Dementia and Alzheimer’s Disease,” American Journal of Clinical Nutrition 2005; 82 (3): 636–643; and http://www.lef.org/protocols/prtcl-006.shtml
58. S. Kono and K. Chen, “Genetic Polymorphisms of Methylenetetrahydrofolate Reductase and Colorectal Cancer and Adenoma,” Cancer Science 2005; 96 (9): 535–542.
59. M. F. Holick, “High Prevalence of Vitamin D Inadequacy and Implications for Health,” Mayo Clin Proc 2006; 81 (3): 353–373.
60. http://www.medscape.com/viewarticle/529426; and E. Giovannucci, Y. Liu, E. B. Rimm, B. W. Hollis, C. S. Fuchs, M. J. Stampfer, and W. C. Willett, “Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men,” J Natl Cancer Inst 2006; 98: 451–459.
61. M. Berwick, Journal of the National Cancer Institute, February 2, 2005; Vol. 97: pp. 195–199.
62. Smedby K. Ekström, Journal of the National Cancer Institute, February 2, 2005; Vol. 97: pp. 199–209.
63. K. M. Egan, Journal of the National Cancer Institute, February 2, 2005; Vol. 97: pp. 161–163.
64. http://www.my.webmd.com/content/Article/101/106006.htm
65. Berube et al., “Cancer Epidemiology Biomarkers & Prevention: Vitamin D and Calcium Intakes from Food or Supplements and Mammographic Breast Density,” Cancer Epidemiol Biomarkers Prev 2005; 14 (7): 1653–1659.
66. http://www.me
dicalnewstoday.com/medicalnews.php?newsid=62413
67. C. Palmieri, T. Macgregor, et al., “Serum 25 Hydroxyvitamin D Levels in Early and Advanced Breast Cancer,” J Clin Pathol 2006 October 17; listed (E-published ahead of print).
68. 2005 Multidisciplinary Prostate Cancer Symposium, cosponsored by the American Society of Clinical Oncology, the Prostate Cancer Foundation, the American Society for Therapeutic Radiology and Oncology, and the Society of Urologic Oncology, Orlando, FL, February 17–19, 2005. News release, Brigham and Women’s Hospital and Harvard University School of Public Health.
69. Reuters Sun, “Vitamin D Helps Lung Cancer Survival—Study,” Monday, April 18, 2005.
70. C. F. Garland, F. C. Garland, et al., “The Role of Vitamin D in Cancer Prevention,” Am J Public Health 2005 December 27 (E-published ahead of print).
71. http://www.abcnews.go.com/Health/wireStory?id=997923
72. S. Gaugris, R. P. Heaney, et al., “Vitamin D Inadequacy Among Postmenopausal Women: A Systematic Review,” QJM 2005; 98 (9): 667–676.
73. M. K. Javaid, S. R. Crozier, et al., “Maternal Vitamin D Status During Pregnancy and Childhood Bone Mass at Age 9 Years: A Longitudinal Study,” The Lancet 2006; 367 (9504): 36–43.
74. Cooper et al., The Lancet 2006; 367: 36–43; and http://www.medscape.com/viewarticle/520990
75. Merlino et al., Arthritis Rheum 2004: 50: 72–77.
76. H. M. Pappa et al., Pediatrics 2006 November; 118 (5): 1950–1961.
77. Chiu et al., American Journal of Clinical Nutrition 2004; 79: 820–825; Liu, “Dietary Calcium, Vitamin D, and the Prevalence of Metabolic Syndrome in Middle-aged and Older U. S. Women,” Diabetes Care 2005; 28 (12): 2926–2932.
78. Mathieu et al., “Vitamin D and Diabetes,” Diabetologia 2005; 48 (7): 1247–1257.
79. P. Pozzilli, S. Manfrini, et al., “Low Levels of 25-hydroxyvitamin D-3 and 1,25-dihydroxyvitamin D-3 in Patients with Newly Diagnosed Type 1 Diabetes,” Hormone and Metabolic Research, 2005; 37 (11): 680–683.
80. http://www.medscape.com/viewarticle/528837
81. http://www.medscape.com/viewarticle/529076
82. R. Scragg and Chest, “Relationship Between Serum 25-hydroxyvitamin D and Pulmonary Function in the Third National Health and Nutrition Examination Survey,” Black PN, 2005; 128 (6): 3792–3798.
83. E. Xystrakis, S. Kusumakar, et al., “Reversing the Defective Induction of IL10 Secreting T-regulatory Cells in Glucocorticoid-resistant Asthma Patients,” Journal of Clinical Investigation 2005 8 December.
84. http://www.medpagetoday.com/Pulmonary/Asthma/tb2/2796. “Vitamin D Deficiency During Pregnancy Also Contributes to Low Birth Weights.”
85. http://news.bbc.co.uk/1/hi/health/4938932.stm
86. W. G. John, K. Noonan, et al., “Hypovitaminosis D is Associated with Reductions in Serum Apolipoprotein A-I But not with Fasting Lipids in British Bangladeshis,” American Journal of Clinical Nutrition 2005; 82 (3): 517–522.
87. J. Marniemi, “Dietary and Serum Vitamins and Minerals as Predictors of Myocardial Infarction and Stroke in Elderly Subjects,” Nutr Metab Cardiovasc Dis 2005 June; 15 (3): 188–197. 43761 (10/2005)
88. H. A. Bischoff-Ferrari et al., Am J Clin Nutr 2006; 84: 18–28.
89. http://www.medscape.com/viewarticle/541149
90. L. Rejnmark, P. Vestergaard, et al., “No Effect of Vitamin K1 Intake on Bone Mineral Density and Fracture Risk in Perimenopausal Women,” Osteoporos Int 2006 May 9 (E-published ahead of print).
91. http://www.reutershealth.com/en/index.html
92. N. Leone and D. Courbon, “Zinc, Copper, and Magnesium and Risks for All-cause, Cancer, and Cardiovascular Mortality,” Epidemiology 2006; 17 (3): 308–314.
93. C. Skibola, Journal of Nutrition, February 2005; Vol. 135: pp. 296–300. News release, University of California, Berkeley.
94. R. Pokan et al., “Oral Magnesium Therapy, Exercise Heart Rate, Exercise Tolerance, and Myocardial Function in Coronary Artery Disease Patients,” British Journal of Sports Medicine 6 July 2006; 40: 773–778; doi: 10.1136/bjsm.2006.027250
95. M. S. Seelig, “The Requirement of Magnesium by the Normal Adult,” American Journal of Clinical Nutrition 14 June 1964: 342–390.
96. M. J. Hoes, “Plasma Concentrations of Magnesium and Vitamin B1 in Alcoholism and Delirium Tremens. Pathogenic and Prognostic Implications,” Acta Psychiatrica Belgica 81 (1) (January-February 1981): 72–84.
97. N. Leone and D. Courbon, op. cit.
98. Massachusetts Institute of Technology news release, December 2, 2004. Study published in the December 2, 2004, issue of Neuron.
99. http://www.medscape.com/viewarticle/504408 and http://www.medscape.com/ viewarticle/504441
100. http://www.medscape.com/viewarticle/528661
101. R. M. van Dam, Diabetes Care 2006; 29: 2238–2243.
102. K. M. Ryder, et al., “Magnesium Intake from Food and Supplements Is Associated with Bone Mineral Density in Healthy Older White Subjects,” J Am Geriatr Soc 2005; 53 (11): 1875–1880.
103. T. O. Carpenter, M. C. Delucia, et al., “A Randomized Controlled Study of Effects of Dietary Magnesium Oxide Supplementation on Bone Mineral Content in Healthy Girls,” J Clin Endocrinol Metab 2006; 91 (12): 4866–4872.
104. D. King, “Magnesium Supplement Intake and C-reactive Protein Levels in Adults,” Nutrition Research 2006; 26 (5): 193–196. 44508 (9/2006)
105. A. R. Folsom and C. P. Hong, “Magnesium Intake and Reduced Risk of Colon Cancer in a Prospective Study of Women,” Am J Epidemiol 2006; 163 (3): 232–235.
106. C. Gontijo-Amaral, M. A. Ribeiro, et al., “Oral Magnesium Supplementation in Asthmatic Children: A Double-Blind Randomized Placebo-Controlled Trial,” Eur J Clin Nutr 2006 June 21 (E-published ahead of print).
107. A. Peikert et al., “Prophylaxis of Migraine with Oral Magnesium: Results from a Prospective, Multicenter, Placebo-Controlled and Double-Blind Randomized Study,” Cephalgia, 1996 June; 16 (4): 257–263.
108. F. Facchinetti et al., “Magnesium Prophylaxis of Mention Migraine: Effects on Intracellular Magnesium,” Headache, 1991 May; 31 (5): 298–301.
109. M. Mousain-Bosc, M. Roche, et al., “Improvement of Neurobehavioral Disorders in Children Supplemented with Magnesium-Vitamin B6. II. Pervasive Developmental Disorder-Autism,” Magnes Res 2006; 19 (1): 46–52.
110. E. T. Jacobs, R. Jiang, D. S. Alberts, E. R. Greenberg, E. W. Gunter, M. R. Karagas, E. Lanza, L. Ratnasinghe, M. E. Reid, A. Schatzkin, S. A. Smith-Warner, K. Wallace, and M. E. Martinez, “Selenium and Colorectal Adenoma: Results of a Pooled Analysis,” J Natl Cancer Inst 2004 November 17; 96 (22): 1669–1675.
111. N. T. Akbaraly, J. Arnaud, et al., “Selenium and Mortality in the Elderly: Results from the EVA Study,” Clin Chem 2005; 51 (11): 2117–2123.
112. A. L. Ray, R. D. Semba, et al., “Low Serum Selenium and Total Carotenoids Predict Mortality among Older Women Living in the Community: The Women’s Health and Aging Studies,” J Nutr 2006; 136 (1): 172–176.
113. J. Arnaud, “Selenium and Mortality in the Elderly: Results from the EVA Study,” Clin Chem 2005 November; 51 (11): 2117–2123 (E-published 2005 August 25. 44052 (3/2006)
114. J. G. Penland, April 4 at the Experimental Biology 2005 meeting in San Diego.
115. http://www.reutershealth.com/en/index.html
116. J. K. Virtanen, S. Voutilainen, et al., “High Dietary Methionine Intake Increases the Risk of Acute Coronary Events in Middle-aged Men,” Nutr Metab Cardiovasc Dis 2006; 16 (2): 113–120.
117. Y. Matuszczak, M. Farid, et al., “Effects of N-Acetyl-L-Cysteine on Glutathione Oxidation and Fatigue During Handgrip Exercise,” Muscle Nerve, 2005; 32 (5): 633–638.
118. D. Yesilbursa, A. Serdar, et al., “Effect of N-Acetyl-L-Cysteine on Oxidative Stress and Ventricular Function in Patients with Myocardial Infarction,” Heart Vessels 2006; 21 (1): 33–37.
119. D. L. Lafleur, C. Pittenger, et al., “N-Acetyl-L-Cysteine Augmentation in Serotonin Reuptake Inhibito
r Refractory Obsessive-Compulsive Disorder,” Psychopharmacology (Berl), 2006; 184 (2): 254–256.
120. S. Ersan, S. Bakir, et al., “Examination of Free Radical Metabolism and Antioxidant Defence System Elements in Patients with Obsessive-Compulsive Disorder,” Prog Neuropsychopharmacol Biol Psychiatry 2006 May 6 (E-published ahead of print).
121. D. C. Rushton, I. D. Ramsay, J. J. Gilkes, et al., “Ferritin and Fertility,” letter to the editor,” The Lancet 337 (8757) (22 June 1991): 1554.
122. http://www.webmd.com/content/Article/122/114601.htm
123. L. B. Trost, Journal of the American Academy of Dermatology May 2006; Vol. 54: pp. 824–844.
124. J. Marniemi, “Dietary and Serum Vitamins and Minerals as Predictors of Myocardial Infarction and Stroke in Elderly Subjects,” Nutr Metab Cardiovasc Dis 2005 June; 15 (3): 188–197. 43761 (10/2005)
125. M. Maes, I. Mihaylova, and J. C. Leunis, “In Chronic Fatigue Syndrome, the Decreased Levels of Omega-3 Polyunsaturated Fatty Acids Are Related to Lowered Serum Zinc and Defects in T cell Activation,” Journal: Neuro Endocrinol Lett 2005 December 28; 26 (6) (E-published ahead of print).
126. B. K. Puri, “The Use of Eicosapentaenoic Acid in the Treatment of Chronic Fatigue Syndrome: Prostaglandins Leukot Essential Fatty Acids.” 2004 April; 70 (4): 399–401.
127. G. Fontani, F. Corradeschi, et al., “Cognitive and Physiological Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation in Healthy Subjects,” Eur J Clin Invest 2005; 35 (11): 691–699.
128. C. Bouzan, J. T. Cohen, et al., “A Quantitative Analysis of Fish Consumption and Stroke Risk,” Am J Prev Med 2005; 29 (4): 347–352.
129. B. Miljanovic and K. A. Trivedi, “Relation Between Dietary N-3 and N-6 Fatty Acids and Clinically Diagnosed Dry Eye Syndrome in Women,” Am J Clin Nutr, 2005; 82 (4): 887–893.
130. http://www.my.webmd.com/content/Article/90/100860.htm; and E. Oken, R. O. Wright, K. P. Kleinman, et al., “Maternal Fish Consumption, Hair Mercury, and Infant Cognition in a U. S. Cohort,” Environ Health Perspect 2005; 113 (10): 1376–1380.
From Fatigued to Fantastic! Page 47